ArticleInternational journal of molecular sciences2025

NCKAP1 Inhibits the Progression of Renal Carcinoma via Modulating Immune Responses and the PI3K/AKT/mTOR Signaling Pathway.

Xin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.